Five years of endocrine therapy or 10? As breast cancer patients weigh the benefits of long-term treatment, a new study might help.

Steady rates of recurrence in women with estrogen receptor-positive disease could influence decisions about long-term therapy

A Michigan Medicine breast oncologist offers advice to help newly diagnosed patients navigate the early days of evaluation and developing a treatment plan.

Recently adjusted prostate cancer treatment guidelines based on new prostate research could affect two-thirds of men

One in eight men are diagnosed with breast cancer. Find out five facts about male breast cancer, including information on risk factors and how its treated.

Stage 4 breast cancer survivor Heather Jose shares how research advancements and precision medicine helped her live 19 years and counting with metastatic cancer.

See how Michigan Medicine's Breast Cancer Ally smart phone app provides individualized information, resources and supportive tools to breast cancer patients.

See how hospital breast cancer resources and family support helped 66 year old Michele Galgoul reduce stress while navigating treatment for stage 3 breast cancer.

A new study finds that women who pursue aggressive cancer treatments, like double mastectomy, are eight times more likely to have substantial employment disruptions.

When will we cure breast cancer? See how breast cancer treatment has evolved since 1960 and find out what the future of breast cancer treatment and research holds.

There is no guaranteed way to prevent breast cancer, but there are ways to reduce your risk. Learn ways to help lower your chances of getting breast cancer.

Varying breast cancer screening guidelines make deciding what age to get a mammogram confusing. Get some clarity from the experts at Michigan Medicine.

Read the results of a new University of Michigan study focused on understanding the factors that influence a woman's perceived breast cancer recurrence risk.

Learn how a powerful combination of a new protein inhibitor and a chemotherapy drug lead to triple negative breast cancer cell death in mice.

Read the findings from a new study examining overtreatment of breast cancer, specifically why many women receive radiation therapy they may not actually need.